Skip to main content
SpringerLink
Log in

Parkinson disease

New guidelines for diagnosis of Parkinson disease

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

At least 10% of diagnoses of Parkinson disease that are made while the patient is alive are not confirmed at autopsy. To help address this issue, the European Federation of Neurology and the Movement Disorder Society European Section have provided evidence-based guidelines and recommendations for clinical diagnosis of Parkinson disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hughes, A. J., Daniel, S. E., Ben-Shlomo, Y. & Lees, A. J. The accuracy of diagnosis of parkinsonian syndromes in a specialized movement disorder service. Brain 125, 861–870 (2002).

    Article  Google Scholar 

  2. Schrag, A., Ben-Shlomo, Y. & Quinn, N. How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry 73, 529–534 (2002).

    Article  CAS  Google Scholar 

  3. Berardelli A. et al. EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease. Eur. J. Neurol. 20, 16–34 (2013).

    Article  CAS  Google Scholar 

  4. Brainin, M. et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces—revised recommendation 2004. Eur. J. Neurol. 11, 577–581 (2004).

    Article  CAS  Google Scholar 

  5. Lees, A. J., Hardy, J. & Revesz, T. Parkinson's disease. Lancet 373, 2055–2066 (2009).

    Article  CAS  Google Scholar 

  6. National Collaborating Centre for Chronic Conditions. Parkinson's Disease: National Clinical Guideline for Management in Primary and Secondary Care (Royal College of Physicians, London, 2006).

  7. Tolosa, E. & Pont-Sunyer, C. Progress in defining the premotor phase of Parkinson's disease. J. Neurol. Sci. 310, 4–8 (2011).

    Article  Google Scholar 

  8. Leone, M. A. et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces—revised recommendations 2012. Eur. J. Neurol. 20, 410–419 (2013).

    Article  CAS  Google Scholar 

  9. Wu, Y., Weidong, L. & Jankovic, J. Preclinical biomarkers of Parkinson disease. Arch. Neurol. 68, 22–30 (2011).

    PubMed  Google Scholar 

Download references

Acknowledgements

E. Tolosa is the Principal Investigator of Grant PI041639 from The Michael J. Fox Foundation for Parkinson Disease.

Author information

Authors and Affiliations

  1. Servicio de Neurologia, Hospital Clinic de Barcelona (IDIBAPS; CIBERNED),

    Maria José Martí & Eduardo Tolosa

  2. CIBERNED), Villarroel 170, Barcelona, 08036, Spain

    Maria José Martí & Eduardo Tolosa

Authors
  1. Maria José Martí
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eduardo Tolosa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Tolosa.

Ethics declarations

Competing interests

E. Tolosa has been a consultant to Boehringer Ingelheim, Novartis, UCB, GSK, Teva and Lundbeck. He has received honoraria for speaking from Boehringer Ingelheim, Novartis, UCB, Solvay, Teva and Lundbeck. M. J. Martí declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martí, M., Tolosa, E. New guidelines for diagnosis of Parkinson disease. Nat Rev Neurol 9, 190–191 (2013). https://doi.org/10.1038/nrneurol.2013.47

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.47

  • Springer Nature Limited

This article is cited by

Search

Navigation